Skip to main content
Clinical Trials/ChiCTR1800016969
ChiCTR1800016969
Active, not recruiting
Not Applicable

尿糖胺聚糖对心脏手术术后急性肾损伤的预测作用

北京朝阳医院麻醉科1 site in 1 country240 target enrollmentStarted: July 9, 2018Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
北京朝阳医院麻醉科
Enrollment
240
Locations
1
Primary Endpoint
急性肾损伤发生率

Overview

Brief Summary

评估尿糖胺聚糖对心脏手术术后急性肾损伤的风险预测作用。

Study Design

Study Type
病因学/相关因素研究
Primary Purpose
队列研究

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 连续纳入;18 岁以上成人;行择期心脏手术(冠脉搭桥、瓣膜置换、或两者同时手术);知情同意

Exclusion Criteria

  • 既往进展型慢性肾疾患;既往肾手术、肾移植;任何原因导致的尿糖胺聚糖的数值无法获得的情况;术前存在急性肾损伤

Arms & Interventions

Case series

Nil

Outcomes

Primary Outcomes

急性肾损伤发生率

Time Frame: At 1d, 2d, 3d, 4d, 5d, 6d, and 7d after surgery

composite primary outcome: postoperative severe acute kidney injury (KDIGO stage 2 or 3, including acute dialysis) and in-hospital death

Time Frame: For severe AKI: Within 7 days after surgery; for in-hospital death: during hospital stay

Secondary Outcomes

  • length of stay in the intensive care unit
  • length of stay in hospital

Investigators

Sponsor
北京朝阳医院麻醉科

Study Sites (1)

Loading locations...

Similar Trials